Intro

This chapter critically examines the influence of pharmaceutical companies on the American healthcare system, drawing insights from a recent book. It contrasts the U.S. model of allowing drug advertisements with New Zealand's stricter regulations, highlighting disparities in healthcare spending and oversight.